Consistently, there are many studies indicating that targeted modulation of DDR and apoptosis can relieve the pathology of many neurodegenerative diseases including HD and SCA3 (Lu et al., 2014; Gao et al., 2015, 2019; Chakraborty et al., 2020). The gene discussed is ATXN3; the disease is neurodegenerative disease.